Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 6Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Lymphoma, Non-Hodgkin 56Lymphoma, Large B-Cell, Diffuse 55Lymphoma, Follicular 48Lymphoma 47Leukemia, Lymphocytic, Chronic, B-Cell 45Lymphoma, Mantle-Cell 41Lymphoma, B-Cell, Marginal Zone 24Lymphoma, B-Cell 22Waldenstrom Macroglobulinemia 17Hodgkin Disease 16Burkitt Lymphoma 16Leukemia 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Recurrence 10Lymphoma, Large-Cell, Immunoblastic 9Neoplasms 7Multiple Myeloma 6Myelodysplastic Syndromes 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Extranodal NK-T-Cell 4Leukemia, Hairy Cell 4Intraocular Lymphoma 4Hematologic Neoplasms 4Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell 3Lymphoma, Primary Effusion 3Immunoblastic Lymphadenopathy 3

Interventions

fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 3Cytarabine 3fludarabine 2Tacrolimus 2Rituximab 2Oxaliplatin 2Methotrexate 2Clofarabine 2Busulfan 2Antilymphocyte Serum 2veltuzumab 1thymoglobulin 1pegfilgrastim 1ofatumumab 1merphos 1ethanolamine oleate 1dinaciclib 1carmustine, poliferprosan 20 drug combination 1acalabrutinib 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Pentetic Acid 1Mycophenolic Acid 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Prolymphocytic × Rituximab × Clear all
NCT00472849 2013-11-26

Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias

M.D. Anderson Cancer Center

Phase 1/2 Completed
92 enrolled 7 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

NCT00452374 2011-11-02

Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

M.D. Anderson Cancer Center

Phase 1/2 Completed
48 enrolled 6 charts
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡